Cardiorenal Syndrome in End-Stage Kidney Disease

Hillel Yaffe Medical Center270 enrolled

Overview

Cardiorenal Syndrome (CRS) is prevalent among end-stage renal disease (ESRD) patients. Recently, its prevalence is rising. There are several different clinical presentations of this syndrome. It has a high rate of morbidity and mortality. The purpose of this study is to find the connection between the heart pathology and its effect on ESRD patients. This will aid in choosing the appropriate medical therapy for these patients, and hopefully, aid in increasing their quality of life, and decrease their morbidity and mortality.

Study Type

OBSERVATIONAL

Enrollment

270

Conditions

End-stage Renal Disease Cardiorenal Syndrome Heart Disease

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * End-stage renal patients Exclusion Criteria: * Cancer patients

Locations (1)

Hillel Yaffe Medical Center

Hadera, Israel

Outcomes

Primary Outcomes

Heart Pathology Identification

Visual identification of heart pathology in ESRD patients using echocardiography by measuring the ejection fraction of the left-ventricle during the systolic and diastolic phases. Valvular pathology is measured by the size of the valve.

Time frame: One hour

Central Contacts

Noa Berar-Yanay, MD

CONTACT

972-4-630-4115 noab@hy.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.